Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sarah K. Medrek"'
Autor:
Sandeep Sahay, Sarah K. Medrek
Publikováno v:
Chest. 153:310-320
In the past decade and a half, the introduction of new therapeutic agents has revolutionized the management of pulmonary arterial hypertension (PAH). These new treatment options have improved the quality of life and survival in PAH. With an armamenta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dba8cd827ee630ec0e12bd4b2528d0f7
https://doi.org/10.1016/j.chest.2017.08.1159
https://doi.org/10.1016/j.chest.2017.08.1159
Autor:
Duc T. Nguyen, Edward A. Graviss, Chad Kloefkorn, Zeenat Safdar, Sarah K. Medrek, Adaani E. Frost
Publikováno v:
Pulmonary Circulation
Pulmonary arterial hypertension (PAH) is a chronic progressive disease that leads to right heart failure and death. Pulmonary arterial capacitance (PAC), defined as stroke volume divided by the pulmonary pulse pressure, has been identified as a progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e123913cdbb586848b1d78b8e50c8437
http://europepmc.org/articles/PMC5467926
http://europepmc.org/articles/PMC5467926
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 196:782-784
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::753de5067b9e24455e479ac3780b5135
https://doi.org/10.1164/rccm.201703-0662rr
https://doi.org/10.1164/rccm.201703-0662rr
Publikováno v:
Chest. 154(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b6620f6bbd72257f678f25fd2e4e3d4
https://pubmed.ncbi.nlm.nih.gov/30409362
https://pubmed.ncbi.nlm.nih.gov/30409362
Publikováno v:
Current Allergy and Asthma Reports. 17
Asthma is a heterogeneous disease characterized by multiple phenotypes. Treatment of patients with severe disease can be challenging. Predictive biomarkers are measurable characteristics that reflect the underlying pathophysiology of asthma and can i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9529544b892e8fc955097d6880e0fef5
https://doi.org/10.1007/s11882-017-0739-5
https://doi.org/10.1007/s11882-017-0739-5
Publikováno v:
Lung India : Official Organ of Indian Chest Society
Lung India, Vol 34, Iss 5, Pp 492-494 (2017)
Lung India, Vol 34, Iss 5, Pp 492-494 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5a1bb4e1cef5af9551db2d5af6eaae
https://pubmed.ncbi.nlm.nih.gov/28869246
https://pubmed.ncbi.nlm.nih.gov/28869246
Autor:
Sarah K, Medrek, Harman S, Kular, Donald R, Lazarus, Stephen, Bujarski, Kalpesh, Patel, Venkata, Bandi
Publikováno v:
Annals of the American Thoracic Society. 14(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::492198798e77550ff66b57ea087f2651
https://pubmed.ncbi.nlm.nih.gov/28665700
https://pubmed.ncbi.nlm.nih.gov/28665700
Publikováno v:
American journal of respiratory and critical care medicine. 196(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f9550ba39f651d4499c88e7b65479f
https://pubmed.ncbi.nlm.nih.gov/28654761
https://pubmed.ncbi.nlm.nih.gov/28654761
Autor:
Sarah K, Medrek, Sandeep, Sahay
Publikováno v:
Chest. 153(2)
In the past decade and a half, the introduction of new therapeutic agents has revolutionized the management of pulmonary arterial hypertension (PAH). These new treatment options have improved the quality of life and survival in PAH. With an armamenta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d430ca97e65db73d0159e7b1cd1fb24f
https://pubmed.ncbi.nlm.nih.gov/28887060
https://pubmed.ncbi.nlm.nih.gov/28887060